New Korea Vaccine Funds Eye Broad Industry Benefits, Partnerships
Diverse Cooperation Models For Synergies
Yuanta Investment, which will launch one of two major new public/private biopharma support funds in South Korea later this year, talks about the strategy behind the initiative and the plans for diverse collaborations with pharma companies both at home and abroad.
